ZDA
GSK icon

Zweig-DiMenna Associates’s GSK GSK Stock Holding History

Zweig-DiMenna Associates’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-7,600
Closed -$365K – 266
2015
Q3 		$365K Buy
7,600
+3,040
+67% +$158K 0.02% 165
2015
Q2 		$237K Buy
+4,560
New +$257K 0.01% 225
2014
Q3 		– Sell
-3,760
Closed -$251K – 283
2014
Q2 		$251K Buy
3,760
+80
+2% +$5.42K 0.01% 214
2014
Q1 		$246K Buy
+3,680
New +$249K 0.01% 178

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Zweig-DiMenna Associates's GSK Position: Q4 2015 in Review

Zweig-DiMenna Associates sold out of GSK (GSK) in Q4 2015, closing a stake of 7,600 shares — an estimated $365K sold.

Zweig-DiMenna Associates first reported a position in GSK in Q1 2014 and held it in 4 quarters. The position peaked at $365K in Q3 2015. 718 funds tracked by Wall St. Rank hold GSK as of Q4 2015.

  • Zweig-DiMenna Associates reported no remaining GSK position as of Q4 2015 after selling out during the quarter.
  • Zweig-DiMenna Associates sold 7,600 GSK shares in Q4 2015, an estimated $365K.
  • Zweig-DiMenna Associates first reported a position in GSK in Q1 2014 and held it in 4 quarters.
  • Zweig-DiMenna Associates's GSK position peaked at $365K in Q3 2015.
  • 718 funds tracked by Wall St. Rank held GSK as of Q4 2015.

Based on Zweig-DiMenna Associates's 13F filing for Q4 2015, filed 10 Feb 2016.